Company intelligence / Profile preview
Zinnia Life Sciences
- Ownership
- Private
- Development stage
- Other
Overview
Zinnia Life Sciences is a commercial-stage Indian pharmaceutical company with 250+ drug products across cardiovascular, anti-diabetic, neuropsychiatry, gastroenterology, and nutraceutical indications, exported to over six countries; clinical trial data is not highlighted, as the company focuses on generics and common formulations[1][3].
- Therapeutic areas
- EndocrinologyGastroenterologyCardiovascularOtherNeurology
- Modalities
- Small moleculeBiologicNutraceutical
- Industry
- Biotech
Drug pipeline
9 assets8 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Zinnia Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zinnia Life Sciences.